HuGE Literature Finder
|
||
Records 1-100
|
Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers.
Breast cancer research and treatment 2019 Jul . Heemskerk-Gerritsen Bernadette A M, Jager Agnes, Koppert Linetta B, Obdeijn A Inge-Marie, Collée Margriet, Meijers-Heijboer Hanne E J, Jenner Denise J, Oldenburg Hester S A, van Engelen Klaartje, de Vries Jakob, van Asperen Christi J, Devilee Peter, Blok Marinus J, Kets C Marleen, Ausems Margreet G E M, Seynaeve Caroline, Rookus Matti A, Hooning Maartje |
|
The yield of full BRCA1/2 genotyping in Israeli Arab high-risk breast/ovarian cancer patients.
Breast cancer research and treatment 2019 Jul . Bernstein-Molho Rinat, Barnes-Kedar Inbal, Ludman Mark D, Reznik Gili, Feldman Hagit Baris, Samra Nadra Nasser, Eilat Avital, Peretz Tamar, Peretz Lilach Peled, Shapira Tamar, Magal Nurit, Kalis Marina Lifshitc, Yerushalmi Rinat, Vinkler Chana, Liberman Sari, Basel-Salmon Lina, Shohat Mordechai, Levy-Lahad Ephrat, Friedman Eitan, Bazak Lily, Goldberg Ya |
|
BRCA mutation characteristics in a series of index cases of breast cancer selected independent of family history.
The breast journal 2019 Jun . Bisgin Atil, Boga Ibrahim, Yalav Orcun, Sonmezler Ozge, Tug Bozdogan Sevc |
|
Benchmarking of a checklist for the identification of familial risk for breast and ovarian cancers in a prospective cohort.
The breast journal 2019 Apr . Rhiem Kerstin, Bücker-Nott Hans-Joachim, Hellmich Martin, Fischer Holger, Ataseven Beyhan, Dittmer-Grabowski Christine, Latos Kunibert, Pelzer Volker, Seifert Manuela, Schmidt Andrea, Rezek Daniela, Groh Ulrich, Meinerz Wolfgang, Crommelinck Dirk, Hahnen Eric, Wesselmann Simone, Schmutzler Rita Kathari |
|
Opportunistic testing of BRCA1, BRCA2 and mismatch repair genes improves the yield of phenotype driven hereditary cancer gene panels.
International journal of cancer 2019 Mar . Feliubadaló Lídia, López-Fernández Adrià, Pineda Marta, Díez Orland, Del Valle Jesús, Gutiérrez-Enríquez Sara, Teulé Alex, González Sara, Stjepanovic Neda, Salinas Mónica, Capellá Gabriel, Brunet Joan, Lázaro Conxi, Balmaña Judith, |
|
Prevalence, spectrum and founder effect of BRCA1 and BRCA2 mutations in Epithelial Ovarian Cancer from Middle East.
Human mutation 2019 Mar . Siraj Abdul K, Bu Rong, Iqbal Kaleem, Siraj Nabil, Al-Haqawi Wael, Al-Badawi Ismail A, Parvathareddy Sandeep Kumar, Masoodi Tariq, Tulbah Asma, Al-Dayel Fouad, Al-Kuraya Khawla |
|
BRCA1 and BRCA2 Germline Mutation Analysis in Hereditary Breast/Ovarian Cancer Families from the Aures Region (Eastern Algeria): First Report.
Pathology oncology research : POR 2019 Feb . Mehemmai Chiraz, Cherbal Farid, Hamdi Yosr, Guedioura Abdelmoumene, Benbrahim Wassila, Bakour Rabah, Abdelhak Son |
|
BRCA1/BRCA2 mutations in Japanese women with ductal carcinoma in situ.
Molecular genetics & genomic medicine 2019 Jan . Liu Yan, Ide Yoshimi, Inuzuka Mayuko, Tazawa Sakiko, Kanada Yoko, Matsunaga Yuki, Kuwayama Takashi, Sawada Terumasa, Akashi-Tanaka Sadako, Nakamura Sei |
|
Prevalence of BRCA1 and BRCA2 pathogenic and likely pathogenic variants in non-selected ovarian carcinoma patients in Brazil.
BMC cancer 2019 Jan 19 (1): 4. Cotrim Deborah Porto, Ribeiro Adriana Regina Gonçalves, Paixão Daniele, de Queiroz Soares Diogo Cordeiro, Jbili Rima, Pandolfi Natasha Carvalho, Cezana Camila, de Cássia Mauro Carine, Mantoan Henrique, Bovolim Graziele, de Brot Louise, Torrezan Giovana Tardin, Carraro Dirce Maria, Baiocchi Glauco, da Cruz Formiga Maria Nirvana, da Costa Alexandre A B |
|
Clinical and Genetic Characteristics of BRCA1/2 Mutation in Korean Ovarian Cancer Patients: A Multicenter Study and Literature Review.
Cancer research and treatment : official journal of Korean Cancer Association 2018 Oct . Kwon Byung Su, Byun Jung Mi, Lee Hyun Joo, Jeong Dae Hoon, Lee Tae Hwa, Shin Kyung-Hwa, Suh Dong Soo, Kim Ki Hyu |
|
Identification of Incidental Germline Mutations in Patients With Advanced Solid Tumors Who Underwent Cell-Free Circulating Tumor DNA Sequencing.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2018 Oct JCO1800328. Slavin Thomas P, Banks Kimberly C, Chudova Darya, Oxnard Geoffrey R, Odegaard Justin I, Nagy Rebecca J, Tsang Kar Wing Kevin, Neuhausen Susan L, Gray Stacy W, Cristofanilli Massimo, Rodriguez Angel A, Bardia Aditya, Leyland-Jones Brian, Janicek Mike F, Lilly Michael, Sonpavde Guru, Lee Christine E, Lanman Richard B, Meric-Bernstam Funda, Kurzrock Razelle, Weitzel Jeffrey |
|
Psychosocial Impact of BRCA Testing in Young Black Breast Cancer Survivors.
Psycho-oncology 2018 Sep . Gonzalez Brian D, Hoogland Aasha I, Kasting Monica L, Cragun Deborah, Kim Jongphil, Ashing Kimlin, Holt Cheryl L, Hughes Halbert Chanita, Pal Tuya, Vadaparampil Susan |
|
BRCA1 and BRCA2 mutations and clinical interpretation in 398 ovarian cancer patients: comparison with breast cancer variants in a similar population.
Human genomics 2018 Aug 12 (1): 39. Cardoso Florencia C, Goncalves Susana, Mele Pablo G, Liria Natalia C, Sganga Leonardo, Diaz Perez Ignacio, Podesta Ernesto J, Solano Angela |
|
Prevalence of germline BRCA mutations among women with carcinoma of the peritoneum or fallopian tube.
Journal of gynecologic oncology 2018 Mar . Choi Min Chul, Bae Jin Sik, Jung Sang Geun, Park Hyun, Joo Won Duk, Song Seung Hun, Lee Chan, Kim Ji Ho, Lee Ki Chan, Lee Sunghoon, Lee Je |
|
BRCAsearch: written pre-test information and BRCA1/2 germline mutation testing in unselected patients with newly diagnosed breast cancer.
Breast cancer research and treatment 2018 Feb 168 (1): 117-126. Nilsson Martin P, Törngren Therese, Henriksson Karin, Kristoffersson Ulf, Kvist Anders, Silfverberg Barbro, Borg Åke, Loman Nikl |
|
Rapid detection of BRCA1/2 recurrent mutations in Chinese breast and ovarian cancer patients with multiplex SNaPshot genotyping panels.
Oncotarget 2018 Jan 9 (8): 7832-7843. Kwong Ava, Ho John C W, Shin Vivian Y, Kurian Allison W, Tai Edmund, Esserman Laura J, Weitzel Jeffery N, Lin Po-Han, Field Michael, Domchek Susan M, Lo Jessica, Ngan Hextan Y S, Ma Edmond S K, Chan Tsun L, Ford James |
|
Mutation analysis of BRCA1/2 mutations with special reference to polymorphic SNPs in Indian breast cancer patients.
The application of clinical genetics 2018 11 59-67. Shah Nidhi D, Shah Parth S, Panchal Yash Y, Katudia Kalpesh H, Khatri Nikunj B, Ray Hari Shankar P, Bhatiya Upti R, Shah Sandip C, Shah Bhavini S, Rao Mandava |
|
Prevalence of pathogenic germline variants detected by multigene sequencing in unselected Japanese patients with ovarian cancer.
Oncotarget 2017 Dec 8 (68): 112258-112267. Hirasawa Akira, Imoto Issei, Naruto Takuya, Akahane Tomoko, Yamagami Wataru, Nomura Hiroyuki, Masuda Kiyoshi, Susumu Nobuyuki, Tsuda Hitoshi, Aoki Daisu |
|
Germline mutations of PALB2 gene in a sequential series of Chinese patients with breast cancer.
Breast cancer research and treatment 2017 Aug . Zhang Kun, Zhou Jiaojiao, Zhu Xuan, Luo Meng, Xu Chunjing, Yu JieKai, Deng Mei, Zheng Shu, Chen Yidi |
|
Young Israeli women with epithelial ovarian cancer: prevalence of BRCA mutations and clinical correlates.
Journal of gynecologic oncology 2017 Jun . Helpman Limor, Zidan Omri, Friedman Eitan, Kalfon Sarit, Perri Tamar, Ben-Baruch Gilad, Korach Jac |
|
Characteristics of BRCA1/2 mutations carriers including large genomic rearrangements in high risk breast cancer patients.
Breast cancer research and treatment 2017 May 163 (1): 139-150. Park Boyoung, Sohn Ji Yeon, Yoon Kyong-Ah, Lee Keun Seok, Cho Eun Hae, Lim Myong Cheol, Yang Moon Jung, Park Soo Jin, Lee Moo Hyun, Lee See Youn, Chang Yoon Jung, Lee Dong Ock, Kong Sun-Young, Lee Eun So |
|
Genomic analysis of inherited breast cancer among Palestinian women: Genetic heterogeneity and a founder mutation in TP53.
International journal of cancer 2017 08 141 (4): 750-756. Lolas Hamameh Suhair, Renbaum Paul, Kamal Lara, Dweik Dima, Salahat Mohammad, Jaraysa Tamara, Abu Rayyan Amal, Casadei Silvia, Mandell Jessica B, Gulsuner Suleyman, Lee Ming K, Walsh Tom, King Mary-Claire, Levy-Lahad Ephrat, Kanaan Moe |
|
Prevalence of BRCA1 and BRCA2 large genomic rearrangements in Tunisian high risk breast/ovarian cancer families: Implications for genetic testing.
Cancer genetics 2017 01 210 22-27. Riahi Aouatef, Chabouni-Bouhamed Habiba, Kharrat Mah |
|
In silico, in vitro and case-control analyses as an effective combination for analyzing BRCA1 and BRCA2 unclassified variants in a population-based sample.
Cancer genetics 2016 Nov 209 (11): 487-492. Rodríguez-Balada Marta, Roig Bàrbara, Martorell Lourdes, Melé Mireia, Salvat Mònica, Vilella Elisabet, Borràs Joan, Gumà Jos |
|
First application of next-generation sequencing in Moroccan breast/ovarian cancer families and report of a novel frameshift mutation of the BRCA1 gene.
Oncology letters 2016 Aug 12 (2): 1192-1196. Jouali Farah, Laarabi Fatima-Zahra, Marchoudi Nabila, Ratbi Ilham, Elalaoui Siham Chafai, Rhaissi Houria, Fekkak Jamal, Sefiani Abdelaz |
|
Identification of Novel BRCA Founder Mutations in Middle Eastern Breast Cancer Patients Using Capture and Sanger Sequencing Analysis.
International journal of cancer 2016 Apr . Bu Rong, Siraj Abdul K, Al-Obaisi Khadija A S, Beg Shaham, Al Hazmi Mohsen, Ajarim Dahish, Tulbah Asma, Al-Dayel Fouad, Al-Kuraya Khawla |
|
Breast cancer risk in Chinese women with BRCA1 or BRCA2 mutations.
Breast cancer research and treatment 2016 Mar . Yao Lu, Sun Jie, Zhang Juan, He Yingjian, Ouyang Tao, Li Jinfeng, Wang Tianfeng, Fan Zhaoqing, Fan Tie, Lin Benyao, Xie Yunt |
|
Investigating the effect of 28 BRCA1 and BRCA2 mutations on their related transcribed mRNA.
Breast cancer research and treatment 2016 Jan . Quiles Francisco, Menéndez Mireia, Tornero Eva, Del Valle Jesús, Teulé Àlex, Palanca Sarai, Izquierdo Angel, Gómez Carolina, Campos Olga, Santamaria Raül, Brunet Joan, Capellá Gabriel, Feliubadaló Lídia, Lázaro Con |
|
BRCA1-2 diagnostic workflow from next-generation sequencing technologies to variant identification and final report.
Genes, chromosomes & cancer 2016 10 55 (10): 803-13. Pilato Brunella, Pinto Rosamaria, De Summa Simona, Petriella Daniela, Lacalamita Rosanna, Danza Katia, Paradiso Angelo, Tommasi Stefan |
|
Design and validation of a next generation sequencing assay for hereditary BRCA1 and BRCA2 mutation testing.
PeerJ 2016 4 e2162. Kang Hyunseok P, Maguire Jared R, Chu Clement S, Haque Imran S, Lai Henry, Mar-Heyming Rebecca, Ready Kaylene, Vysotskaia Valentina S, Evans Eric |
|
Targeted sequencing of BRCA1 and BRCA2 across a large unselected breast cancer cohort suggests that one-third of mutations are somatic.
Annals of oncology : official journal of the European Society for Medical Oncology 2016 08 27 (8): 1532-8. Winter C, Nilsson M P, Olsson E, George A M, Chen Y, Kvist A, Törngren T, Vallon-Christersson J, Hegardt C, Häkkinen J, Jönsson G, Grabau D, Malmberg M, Kristoffersson U, Rehn M, Gruvberger-Saal S K, Larsson C, Borg Å, Loman N, Saal L |
|
Impact of Age at Primary Breast Cancer on Contralateral Breast Cancer Risk in BRCA1/2 Mutation Carriers.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2015 Dec . van den Broek Alexandra J, van 't Veer Laura J, Hooning Maartje J, Cornelissen Sten, Broeks Annegien, Rutgers Emiel J, Smit Vincent T H B M, Cornelisse Cees J, van Beek Mike, Janssen-Heijnen Maryska L, Seynaeve Caroline, Westenend Pieter J, Jobsen Jan J, Siesling Sabine, Tollenaar Rob A E M, van Leeuwen Flora E, Schmidt Marjanka |
|
Dissimilarity between sporadic, non-BRCA1/2 families and hereditary breast cancer, linked to BRCA genes, in the Tunisian population.
Breast cancer (Tokyo, Japan) 2015 Oct . Riahi Aouatef, Gourabi Mohamel El, Chabouni-Bouhamed Habi |
|
Effect of BRCA2 mutation on familial breast cancer survival: A systematic review and meta-analysis.
Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 2015 Oct 35 (5): 629-34. Shao Jun, Yang Jie, Wang Jun-Nai, Qiao Long, Fan Wei, Gao Qing-Lei, Feng Yao-J |
|
Germline Mutations of BRCA1 and BRCA2 in Korean Ovarian Cancer Patients: Finding Founder Mutations.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2015 Oct 25 (8): 1386-91. Choi Min Chul, Heo Jin-Hyung, Jang Ja-Hyun, Jung Sang Geun, Park Hyun, Joo Won Duk, Lee Chan, Lee Je Ho, Lee Jun Mo, Hwang Yoon Young, Kim Seung |
|
Identification of germline genetic mutations in patients with pancreatic cancer.
Cancer 2015 Oct . Salo-Mullen Erin E, O'Reilly Eileen M, Kelsen David P, Ashraf Asad M, Lowery Maeve A, Yu Kenneth H, Reidy Diane L, Epstein Andrew S, Lincoln Anne, Saldia Amethyst, Jacobs Lauren M, Rau-Murthy Rohini, Zhang Liying, Kurtz Robert C, Saltz Leonard, Offit Kenneth, Robson Mark E, Stadler Zsofia |
|
A high frequency of BRCA mutations in young black women with breast cancer residing in Florida.
Cancer 2015 Aug . Pal Tuya, Bonner Devon, Cragun Deborah, Monteiro Alvaro N A, Phelan Catherine, Servais Lily, Kim Jongphil, Narod Steven A, Akbari Mohammad R, Vadaparampil Susan |
|
Deleterious BRCA1/2 mutations in an urban population of Black women.
Breast cancer research and treatment 2015 Aug 153 (1): 201-9. Lynce Filipa, Smith Karen Lisa, Stein Julie, DeMarco Tiffani, Wang Yiru, Wang Hongkun, Fries Melissa, Peshkin Beth N, Isaacs Claudi |
|
Population-Wide Screening for Germline BRCA1 and BRCA2 Mutations: Too Much of a Good Thing?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2015 Aug . Yurgelun Matthew B, Hiller Elaine, Garber Judy |
|
Double PALB2 and BRCA1/BRCA2 mutation carriers are rare in breast cancer and breast-ovarian cancer syndrome families from the French Canadian founder population.
Oncology letters 2015 Jun 9 (6): 2787-2790. Ancot Frédéric, Arcand Suzanna L, Mes-Masson Anne-Marie, Provencher Diane M, Tonin Patricia |
|
Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation Carriers.
JAMA oncology 2015 Jun 1 (3): 306-13. Metcalfe Kelly, Lynch Henry T, Foulkes William D, Tung Nadine, Kim-Sing Charmaine, Olopade Olufunmilayo I, Eisen Andrea, Rosen Barry, Snyder Carrie, Gershman Shelley, Sun Ping, Narod Steven |
|
The prevalence and spectrum of BRCA1 and BRCA2 mutations in Korean population: recent update of the Korean Hereditary Breast Cancer (KOHBRA) study.
Breast cancer research and treatment 2015 May 151 (1): 157-68. Kang Eunyoung, Seong Moon-Woo, Park Sue K, Lee Jong Won, Lee Jihyoun, Kim Lee Su, Lee Jeong Eon, Kim Sung Yong, Jeong Joon, Han Sang Ah, Kim Sung-Won, |
|
Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond.
JAMA oncology 2015 Apr 1 (1): 23-32. Hansford Samantha, Kaurah Pardeep, Li-Chang Hector, Woo Michelle, Senz Janine, Pinheiro Hugo, Schrader Kasmintan A, Schaeffer David F, Shumansky Karey, Zogopoulos George, Santos Teresa Almeida, Claro Isabel, Carvalho Joana, Nielsen Cydney, Padilla Sarah, Lum Amy, Talhouk Aline, Baker-Lange Katie, Richardson Sue, Lewis Ivy, Lindor Noralane M, Pennell Erin, MacMillan Andree, Fernandez Bridget, Keller Gisella, Lynch Henry, Shah Sohrab P, Guilford Parry, Gallinger Steven, Corso Giovanni, Roviello Franco, Caldas Carlos, Oliveira Carla, Pharoah Paul D P, Huntsman David |
|
Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian.
Cancer 2015 Jan 121 (2): 269-75. Mersch Jacqueline, Jackson Michelle A, Park Minjeong, Nebgen Denise, Peterson Susan K, Singletary Claire, Arun Banu K, Litton Jennifer |
|
Identification of a comprehensive spectrum of genetic factors for hereditary breast cancer in a Chinese population by next-generation sequencing.
PloS one 2015 10 (4): e0125571. Yang Xiaochen, Wu Jiong, Lu Jingsong, Liu Guangyu, Di Genhong, Chen Canming, Hou Yifeng, Sun Menghong, Yang Wentao, Xu Xiaojing, Zhao Ying, Hu Xin, Li Daqiang, Cao Zhigang, Zhou Xiaoyan, Huang Xiaoyan, Liu Zhebin, Chen Huan, Gu Yanzi, Chi Yayun, Yan Xia, Han Qixia, Shen Zhenzhou, Shao Zhimin, Hu Zh |
|
Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis.
Journal of the National Cancer Institute 2014 Jun 106 (6): dju091. Friebel Tara M, Domchek Susan M, Rebbeck Timothy |
|
Underestimation of risk of a BRCA1 or BRCA2 mutation in women with high-grade serous ovarian cancer by BRCAPRO: a multi-institution study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2014 Apr 32 (12): 1249-55. Daniels Molly S, Babb Sheri A, King Robin H, Urbauer Diana L, Batte Brittany A L, Brandt Amanda C, Amos Christopher I, Buchanan Adam H, Mutch David G, Lu Karen |
|
Mutation analysis of PALB2 in BRCA1 and BRCA2-negative breast and/or ovarian cancer families from Eastern Ontario, Canada.
Hereditary cancer in clinical practice 2014 12 (1): 19. Hartley Taila, Cavallone Luca, Sabbaghian Nelly, Silva-Smith Rachel, Hamel Nancy, Aleynikova Olga, Smith Erika, Hastings Valerie, Pinto Pedro, Tischkowitz Marc, Tomiak Eva, Foulkes William |
|
TP53 p.R337H prevalence in a series of Brazilian hereditary breast cancer families.
Hereditary cancer in clinical practice 2014 12 (1): 8. Cury Nathalia M, Ferraz Victor Ef, Silva Wilson |
|
Increased rate of phenocopies in all age groups in BRCA1/BRCA2 mutation kindred, but increased prospective breast cancer risk is confined to BRCA2 mutation carriers.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2013 Dec 22 (12): 2269-76. Evans D Gareth R, Ingham Sarah L, Buchan Iain, Woodward Emma R, Byers Helen, Howell Anthony, Maher Eamonn R, Newman William G, Lalloo Fio |
|
Phenotypic heterogeneity of hereditary gynecologic cancers: a report from the Creighton hereditary cancer registry.
Familial cancer 2013 Dec 12 (4): 719-40. Casey Murray Joseph, Bewtra Chhanda, Lynch Henry T, Snyder Carrie, Stacy Mark, Watson Patri |
|
Prevalence of BRCA mutations among women with triple-negative breast cancer (TNBC) in a genetic counseling cohort.
Annals of surgical oncology 2013 Oct 20 (10): 3254-8. Greenup Rachel, Buchanan Adam, Lorizio Wendy, Rhoads Keelia, Chan Salina, Leedom Tracey, King Robin, McLennan Jane, Crawford Beth, Kelly Marcom P, Shelley Hwang |
|
Functional analysis of BRCA1 missense variants of uncertain significance in Japanese breast cancer families.
Journal of human genetics 2013 Sep 58 (9): 618-21. Kawaku Shogo, Sato Rieko, Song Hao, Bando Yuko, Arinami Tadao, Noguchi Emi |
|
Risk of pancreatic cancer in breast cancer families from the breast cancer family registry.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2013 May 22 (5): 803-11. Mocci Evelina, Milne Roger L, Méndez-Villamil Elena Yuste, Hopper John L, John Esther M, Andrulis Irene L, Chung Wendy K, Daly Mary, Buys Saundra S, Malats Nuria, Goldgar David |
|
The prevalence of BRCA mutations among familial breast cancer patients in Korea: results of the Korean Hereditary Breast Cancer study.
Familial cancer 2013 Mar 12 (1): 75-81. Han Sang-Ah, Kim Sung-Won, Kang Eunyoung, Park Sue K, Ahn Sei-Hyun, Lee Min Hyuk, Nam Seok-Jin, Han Wonshik, Bae Young Tae, Kim Hyun-Ah, Cho Young Up, Chang Myung Chul, Paik Nam Sun, Hwang Ki-Tae, Kim Sei Joong, Noh Dong-Young, Choi Doo Ho, Noh Woo-Chul, Kim Lee Su, Kim Ku Sang, Suh Young Jin, Lee Jeong Eon, Jung Yongsik, Moon Byung-In, Yang Jung-Hyun, Son Byung Ho, Yom Cha Kyong, Kim Sung Yong, Lee Hyde, Jung Sung Hoo, |
|
The risk of primary and contralateral breast cancer after ovarian cancer in BRCA1/BRCA2 mutation carriers: Implications for counseling.
Cancer 2013 Mar 119 (5): 955-62. Vencken Peggy M L H, Kriege Mieke, Hooning Maartje, Menke-Pluymers Marian B, Heemskerk-Gerritsen Bernadette A M, van Doorn Lena C, Collée Margriet M, Jager Agnes, van Montfort Cees, Burger Curt W, Seynaeve Caroli |
|
BRCA1 and BRCA2 Gene Mutations Screening In Sporadic Breast Cancer Patients In Kazakhstan.
Central Asian journal of global health 2013 2 (1): 29. Akilzhanova Ainur R, Nyshanbekkyzy Bagdat, Nurkina Zhannur M, Shtephanov Ivan I, Makishev Abay K, Adylkhanov Tasbolat A, Rakhypbekov Tolebay K, Ramanculov Erlan M, Momynaliev Kuvat |
|
Evaluation of the need for routine clinical testing of PALB2 c.1592delT mutation in BRCA negative Northern Finnish breast cancer families.
BMC medical genetics 2013 14 82. Haanpää Maria, Pylkäs Katri, Moilanen Jukka S, Winqvist Robe |
|
Low prevalence of SLX4 loss-of-function mutations in non-BRCA1/2 breast and/or ovarian cancer families.
European journal of human genetics : EJHG 2012 Dec . de Garibay GR, Díaz A, Gaviña B, Romero A, Garre P, Vega A, Blanco A, Tosar A, Díez O, Pérez-Segura P, Díaz-Rubio E, Caldés T, de la Hoya M |
|
The penetrance of ductal carcinoma in situ among BRCA1 and BRCA2 mutation carriers.
Breast cancer research and treatment 2012 Nov . Mazzola E, Cheng SC, Parmigiani G |
|
Effect of the MDM2 promoter polymorphisms SNP309T>G and SNP285G>C on the risk of ovarian cancer in BRCA1 mutation carriers.
BMC cancer 2012 Oct 12 (1): 1. Bjørnslett M, Knappskog S, Lønning PE, Dørum A |
|
Germline BRCA1 and BRCA2 mutations in ovarian cancer: utility of a histology-based referral strategy.
Obstetrics and gynecology 2012 Aug 120 (2 Pt 1): 235-40. Schrader Kasmintan A, Hurlburt Jane, Kalloger Steve E, Hansford Samantha, Young Sean, Huntsman David G, Gilks C Blake, McAlpine Jessica |
|
Anthropometric measures and risk of ovarian cancer among BRCA1 and BRCA2 mutation carriers.
Obesity (Silver Spring, Md.) 2012 Jun 20 (6): 1288-92. McGee Jacob, Kotsopoulos Joanne, Lubinski Jan, Lynch Henry T, Rosen Barry, Tung Nadine, Kim-Sing Charmaine, Karlan Beth, Foulkes William D, Ainsworth Peter, Ghadirian Parviz, Senter Leigha, Eisen Andrea, Sun Ping, Narod Steven A, |
|
Prevalence of BRCA1 and BRCA2 mutations in non-familial breast cancer patients with high risks in Korea: the Korean Hereditary Breast Cancer (KOHBRA) Study.
Breast cancer research and treatment 2012 Jun 133 (3): 1143-52. Son Byung Ho, Ahn Sei Hyun, Kim Sung-Won, Kang Eunyoung, Park Sue K, Lee Min Hyuk, Noh Woo-Chul, Kim Lee Su, Jung Yongsik, Kim Ku Sang, Noh Dong-Young, Moon Byung-In, Suh Young Jin, Lee Jeong Eon, Choi Doo Ho, Kim Sung Yong, Jung Sung Hoo, Yom Cha Kyong, Lee Hyde, Yang Jung-Hyun, |
|
Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers.
Human mutation 2012 Apr 33 (4): 690-702. Ramus Susan J, Antoniou Antonis C, Kuchenbaecker Karoline B, Soucy Penny, Beesley Jonathan, Chen Xiaoqing, McGuffog Lesley, Sinilnikova Olga M, Healey Sue, Barrowdale Daniel, Lee Andrew, Thomassen Mads, Gerdes Anne-Marie, Kruse Torben A, Jensen Uffe Birk, Skytte Anne-Bine, Caligo Maria A, Liljegren Annelie, Lindblom Annika, Olsson Håkan, Kristoffersson Ulf, Stenmark-Askmalm Marie, Melin Beatrice, , Domchek Susan M, Nathanson Katherine L, Rebbeck Timothy R, Jakubowska Anna, Lubinski Jan, Jaworska Katarzyna, Durda Katarzyna, Z?owocka El?bieta, Gronwald Jacek, Huzarski Tomasz, Byrski Tomasz, Cybulski Cezary, Toloczko-Grabarek Aleksandra, Osorio Ana, Benitez Javier, Duran Mercedes, Tejada Maria-Isabel, Hamann Ute, Rookus Matti, van Leeuwen Flora E, Aalfs Cora M, Meijers-Heijboer Hanne E J, van Asperen Christi J, van Roozendaal K E P, Hoogerbrugge Nicoline, Collée J Margriet, Kriege Mieke, van der Luijt Rob B, , , Peock Susan, Frost Debra, Ellis Steve D, Platte Radka, Fineberg Elena, Evans D Gareth, Lalloo Fiona, Jacobs Chris, Eeles Ros, Adlard Julian, Davidson Rosemarie, Eccles Diana, Cole Trevor, Cook Jackie, Paterson Joan, Douglas Fiona, Brewer Carole, Hodgson Shirley, Morrison Patrick J, Walker Lisa, Porteous Mary E, Kennedy M John, Pathak Harsh, Godwin Andrew K, Stoppa-Lyonnet Dominique, Caux-Moncoutier Virginie, de Pauw Antoine, Gauthier-Villars Marion, Mazoyer Sylvie, Léoné Mélanie, Calender Alain, Lasset Christine, Bonadona Valérie, Hardouin Agnès, Berthet Pascaline, Bignon Yves-Jean, Uhrhammer Nancy, Faivre Laurence, Loustalot Catherine, , Buys Saundra, Daly Mary, Miron Alex, Terry Mary Beth, Chung Wendy K, John Esther M, Southey Melissa, Goldgar David, Singer Christian F, Tea Muy-Kheng, Pfeiler Georg, Fink-Retter Anneliese, Hansen Thomas v O, Ejlertsen Bent, Johannsson Oskar Th, Offit Kenneth, Kirchhoff Tomas, Gaudet Mia M, Vijai Joseph, Robson Mark, Piedmonte Marion, Phillips Kelly-Anne, Van Le Linda, Hoffman James S, Ewart Toland Amanda, Montagna Marco, Tognazzo Silvia, Imyanitov Evgeny, Issacs Claudine, Janavicius Ramunas, Lazaro Conxi, Blanco Iganacio, Tornero Eva, Navarro Matilde, Moysich Kirsten B, Karlan Beth Y, Gross Jenny, Olah Edith, Vaszko Tibor, Teo Soo-Hwang, Ganz Patricia A, Beattie Mary S, Dorfling Cecelia M, van Rensburg Elizabeth J, Diez Orland, Kwong Ava, Schmutzler Rita K, Wappenschmidt Barbara, Engel Christoph, Meindl Alfons, Ditsch Nina, Arnold Norbert, Heidemann Simone, Niederacher Dieter, Preisler-Adams Sabine, Gadzicki Dorotehea, Varon-Mateeva Raymonda, Deissler Helmut, Gehrig Andrea, Sutter Christian, Kast Karin, Fiebig Britta, Schäfer Dieter, Caldes Trinidad, de la Hoya Miguel, Nevanlinna Heli, Aittomäki Kristiina, Plante Marie, Spurdle Amanda B, , Neuhausen Susan L, Ding Yuan Chun, Wang Xianshu, Lindor Noralane, Fredericksen Zachary, Pankratz V Shane, Peterlongo Paolo, Manoukian Siranoush, Peissel Bernard, Zaffaroni Daniela, Bonanni Bernardo, Bernard Loris, Dolcetti Riccardo, Papi Laura, Ottini Laura, Radice Paolo, Greene Mark H, Mai Phuong L, Andrulis Irene L, Glendon Gord, Ozcelik Hilmi, , Pharoah Paul D P, Gayther Simon A, Simard Jacques, Easton Douglas F, Couch Fergus J, Chenevix-Trench Georgia, |
|
Impact of lifestyle factors on preneoplastic changes in prophylactic oophorectomies of BRCA mutation carriers.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2012 Mar 21 (2): 199-204. Primas Helga, Kroiss Regina, Kalteis Karin, Rappaport Christine, Muhr Daniela, Primas Christian, Kubista Ernst, Horvat Reinhard, Oefner Peter, Singer Christian, Wagner And The Austrian Hereditary Breast And Ovarian Cancer Group Tere |
|
Predictive factors for BRCA1/BRCA2 mutations in women with ductal carcinoma in situ.
Cancer 2012 Mar 118 (6): 1515-22. Bayraktar Soley, Elsayegh Nisreen, Gutierrez Barrera Angelica M, Lin Heather, Kuerer Henry, Tasbas Tunc, Muse Kimberly I, Ready Kaylene, Litton Jennifer, Meric-Bernstam Funda, Hortobagyi Gabriel N, Albarracin Constance T, Arun Ba |
|
Appendectomy and cancer risk in Jewish BRCA1 and BRCA2 mutation carriers.
Breast cancer research and treatment 2012 Feb 131 (3): 981-5. Bernholtz Shiri, Jakobson-Setton Ariella, Korach Jacob, Ben Baruch Gilad, Laitman Yael, Friedman Eit |
|
[The clinical importance of a genetic analysis of moderate-risk cancer susceptibility genes in breast and other cancer patients from the Czech Republic].
Klinická onkologie : casopis Ceské a Slovenské onkologické spolecnosti 2012 25 Suppl S59-66. Pohlreich P, Kleibl Z, Kleiblová P, Janatová M, Soukupová J, Machá?ková E, Házová J, Vaší?ková P, S?ahlová Hrabincová E, Navrátilová M, Svoboda M, Foretová |
|
BRCA1 and BRCA2 mutations in breast cancer patients from Venezuela.
Biological research 2012 45 (2): 117-30. Lara Karlena, Consigliere Nigmet, Pérez Jorge, Porco Antoniet |
|
Identification of BRCA1/2 founder mutations in Southern Chinese breast cancer patients using gene sequencing and high resolution DNA melting analysis.
PloS one 2012 7 (9): e43994. Kwong Ava, Ng Enders Kai On, Wong Chris Lei Po, Law Fian Bic Fai, Au Tommy, Wong Hong Nei, Kurian Allison W, West Dee W, Ford James M, Ma Edmond Siu Kw |
|
Cancer risk in Jewish BRCA1 and BRCA2 mutation carriers: effects of oral contraceptive use and parental origin of mutation.
Breast cancer research and treatment 2011 Sep 129 (2): 557-63. Bernholtz Shiri, Laitman Yael, Kaufman Bella, Paluch Shimon Shani, Friedman Eit |
|
Clinical characteristics of affected BRCA1 and BRCA2 mutation carriers in an underserved population.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 May 29 (15_suppl): 1532. El-Masry M, Ricker C, Spicer D V, Tripathy |
|
Predictors and prevalence of germ-line BRCA1 and BRCA2 mutations in high-risk patients screened at a community hospital.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 May 29 (15_suppl): e11124. Riaz S S, Ahsan S, Bloom R |
|
Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
Breast cancer research : BCR 2011 13 (1): R20. Kuusisto Kirsi M, Bebel Aleksandra, Vihinen Mauno, Schleutker Johanna, Sallinen Satu-Lee |
|
Germline mutations of BRCA1 and BRCA2 genes in Turkish breast, ovarian, and prostate cancer patients.
Cancer genetics and cytogenetics 2010 Dec 203 (2): 230-7. Manguo?lu Esra, Güran Sefik, Yamaç Deniz, Colak Taner, Sim?ek Mehmet, Baykara Mehmet, Akayd?n Mustafa, Lüleci Güv |
|
Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2010 Nov 19 (11): 2859-68. Engel Christoph, Versmold Beatrix, Wappenschmidt Barbara, Simard Jacques, Easton Douglas F, Peock Susan, Cook Margaret, Oliver Clare, Frost Debra, Mayes Rebecca, Evans D Gareth, Eeles Rosalind, Paterson Joan, Brewer Carole, , McGuffog Lesley, Antoniou Antonis C, Stoppa-Lyonnet Dominique, Sinilnikova Olga M, Barjhoux Laure, Frenay Marc, Michel Cécile, Leroux Dominique, Dreyfus Helene, Toulas Christine, Gladieff Laurence, Uhrhammer Nancy, Bignon Yves-Jean, Meindl Alfons, Arnold Norbert, Varon-Mateeva Raymonda, Niederacher Dieter, Preisler-Adams Sabine, Kast Karin, Deissler Helmut, Sutter Christian, Gadzicki Dorothea, Chenevix-Trench Georgia, Spurdle Amanda B, Chen Xiaoqing, Beesley Jonathan, , Olsson Håkan, Kristoffersson Ulf, Ehrencrona Hans, Liljegren Annelie, , van der Luijt Rob B, van Os Theo A, van Leeuwen Flora E, , Domchek Susan M, Rebbeck Timothy R, Nathanson Katherine L, Osorio Ana, Ramón y Cajal Teresa, Konstantopoulou Irene, Benítez Javier, Friedman Eitan, Kaufman Bella, Laitman Yael, Mai Phuong L, Greene Mark H, Nevanlinna Heli, Aittomäki Kristiina, Szabo Csilla I, Caldes Trinidad, Couch Fergus J, Andrulis Irene L, Godwin Andrew K, Hamann Ute, Schmutzler Rita K, |
|
Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 May 28 (14): 2404-10. Malone Kathleen E, Begg Colin B, Haile Robert W, Borg Ake, Concannon Patrick, Tellhed Lina, Xue Shanyan, Teraoka Sharon, Bernstein Leslie, Capanu Marinela, Reiner Anne S, Riedel Elyn R, Thomas Duncan C, Mellemkjaer Lene, Lynch Charles F, Boice John D, Anton-Culver Hoda, Bernstein Jonine |
|
High penetrances of BRCA1 and BRCA2 mutations confirmed in a prospective series.
Hereditary cancer in clinical practice 2010 8 (1): 2. Møller Pål, Mæhle Lovise, Engebretsen Lars F, Ludvigsen Trond, Jonsrud Christoffer, Apold Jaran, Vabø Anita, Clark Ne |
|
BRCA1 and BRCA2 germline mutations in Korean ovarian cancer patients.
Journal of cancer research and clinical oncology 2009 Nov 135 (11): 1593-9. Lim Myong Cheol, Kang Sokbom, Seo Sang-Soo, Kong Sun-Young, Lee Bo-Yon, Lee Seon-Kyung, Park Sang-Yo |
|
Functional redundancy of exon 12 of BRCA2 revealed by a comprehensive analysis of the c.6853A>G (p.I2285V) variant.
Human mutation 2009 Nov 30 (11): 1543-50. Li Lili, Biswas Kajal, Habib Laura Anne, Kuznetsov Sergey G, Hamel Nancy, Kirchhoff Tomas, Wong Nora, Armel Susan, Chong George, Narod Steven A, Claes Kathleen, Offit Kenneth, Robson Mark E, Stauffer Stacey, Sharan Shyam K, Foulkes William |
|
Evaluating the performance of models for predicting the BRCA germline mutations in Han Chinese familial breast cancer patients.
Breast cancer research and treatment 2009 Aug 116 (3): 563-70. Rao Nan-Yan, Hu Zhen, Yu Jin-Ming, Li Wen-Feng, Zhang Bin, Su Feng-Xi, Wu Jiong, Shen Zhen-Zhou, Huang Wei, Shao Zhi-Mi |
|
Missense polymorphisms in BRCA1 and BRCA2 and risk of breast and ovarian cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009 Aug 18 (8): 2339-42. Dombernowsky Sarah Louise, Weischer Maren, Freiberg Jacob Johannes, Bojesen Stig Egil, Tybjaerg-Hansen Anne, Nordestgaard Børge Grøn |
|
BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer.
Cancer 2009 May 115 (10): 2222-33. Hall Michael J, Reid Julia E, Burbidge Lynn A, Pruss Dmitry, Deffenbaugh Amie M, Frye Cynthia, Wenstrup Richard J, Ward Brian E, Scholl Thomas A, Noll Walter |
|
Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009 Feb 15 (3): 1112-20. Agalliu Ilir, Gern Robert, Leanza Suzanne, Burk Robert |
|
Penetrance of BRCA1/BRCA2 specific gene mutations in Iranian women with breast cancer.
Saudi medical journal 2009 Jan 30 (1): 41-4. Hashemian Amir H, Hajizadeh Ebrahim, Kazemnejad Anoshirvan, Atri Morteza, Mehdipour Parv |
|
A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2 genes based on cancer family history.
Breast cancer research : BCR 2009 11 (1): R8. Gómez García Encarna B, Oosterwijk Jan C, Timmermans Maarten, van Asperen Christi J, Hogervorst Frans B L, Hoogerbrugge Nicoline, Oldenburg Rogier, Verhoef Senno, Dommering Charlotte J, Ausems Margreet G E M, van Os Theo A M, van der Hout Annemarie H, Ligtenberg Marjolijn, van den Ouweland Ans, van der Luijt Rob B, Wijnen Juul T, Gille Jan J P, Lindsey Patrick J, Devilee Peter, Blok Marinus J, Vreeswijk Maaike P |
|
Cross-sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer.
Cancer science 2008 Oct 99 (10): 1967-76. Sugano Kokichi, Nakamura Seigo, Ando Jiro, Takayama Shin, Kamata Hiroyuki, Sekiguchi Isao, Ubukata Megumi, Kodama Tetsuro, Arai Masami, Kasumi Fujio, Hirai Yasuo, Ikeda Tadashi, Jinno Hiromitsu, Kitajima Masaki, Aoki Daisuke, Hirasawa Akira, Takeda Yuko, Yazaki Kumiko, Fukutomi Takashi, Kinoshita Takayuki, Tsunematsu Ryuichiro, Yoshida Teruhiko, Izumi Masako, Umezawa Shino, Yagata Hiroshi, Komatsu Hiroko, Arimori Naoko, Matoba Noriko, Gondo Nobuhisa, Yokoyama Shiro, Miki Yosh |
|
The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008 May 14 (9): 2861-9. Milne Roger L, Osorio Ana, Cajal Teresa Ramón Y, Vega Ana, Llort Gemma, de la Hoya Miguel, Díez Orland, Alonso M Carmen, Lazaro Conxi, Blanco Ignacio, Sánchez-de-Abajo Ana, Caldés Trinidad, Blanco Ana, Graña Begoña, Durán Mercedes, Velasco Eladio, Chirivella Isabel, Cardeñosa Eva Esteban, Tejada María-Isabel, Beristain Elena, Miramar María-Dolores, Calvo María-Teresa, Martínez Eduardo, Guillén Carmen, Salazar Raquel, San Román Carlos, Antoniou Antonis C, Urioste Miguel, Benítez Javi |
|
Meta-analysis of BRCA1 and BRCA2 penetrance.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007 Apr 25 (11): 1329-33. Chen Sining, Parmigiani Giovan |
|
Mutation analysis of BRCA1 and BRCA2 from 793 Korean patients with sporadic breast cancer.
Clinical genetics 2006 Dec 70 (6): 496-501. Han S-H, Lee K-R, Lee D-G, Kim B-Y, Lee K-E, Chung W |
|
Characterization of BRCA1 and BRCA2 mutations in a large United States sample.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006 Feb 24 (6): 863-71. Chen Sining, Iversen Edwin S, Friebel Tara, Finkelstein Dianne, Weber Barbara L, Eisen Andrea, Peterson Leif E, Schildkraut Joellen M, Isaacs Claudine, Peshkin Beth N, Corio Camille, Leondaridis Leoni, Tomlinson Gail, Dutson Debra, Kerber Rich, Amos Christopher I, Strong Louise C, Berry Donald A, Euhus David M, Parmigiani Giovan |
|
Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000.
Journal of the National Cancer Institute 2006 Jan 98 (2): 116-22. Tryggvadottir Laufey, Sigvaldason Helgi, Olafsdottir Gudridur H, Jonasson Jon G, Jonsson Thorvaldur, Tulinius Hrafn, Eyfjörd Jorunn |
|
Insulin-like growth factor-1 genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating insulin-like growth factor-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006 16 Suppl 2 (): 497. Jernström H, Sandberg T, Bågeman E, Borg A, Olsson |
|
BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases.
Cancer 2005 Dec 104 (12): 2807-16. Pal Tuya, Permuth-Wey Jenny, Betts Judith A, Krischer Jeffrey P, Fiorica James, Arango Hector, LaPolla James, Hoffman Mitchell, Martino Martin A, Wakeley Katie, Wilbanks George, Nicosia Santo, Cantor Alan, Sutphen Rebec |
|
BRCA1 and BRCA2 germline mutations in Korean patients with sporadic breast cancer.
Human mutation 2004 Oct 24 (4): 350. Seo Jae Hong, Cho Dae-Yeon, Ahn Se-Hyun, Yoon Kyung-Sik, Kang Chang-Soo, Cho Hyun Mi, Lee Hyeon Sook, Choe Jae Jin, Choi Cheul Won, Kim Byung Soo, Shin Sang Won, Kim Yeul Hong, Kim Jun Suk, Son Gil-Soo, Lee Jae-Bok, Koo Bum Hw |
|
Predictors of cognitive appraisals following genetic testing for BRCA1 and BRCA2 mutations.
Journal of behavioral medicine 2004 Aug 27 (4): 373-92. Halbert Chanita Hughes, Schwartz Marc D, Wenzel Lari, Narod Steven, Peshkin Beth N, Cella David, Lerman Car |
|
Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
Journal of the National Cancer Institute 2004 Jul 96 (14): 1094-8. Jernström H, Lubinski J, Lynch H T, Ghadirian P, Neuhausen S, Isaacs C, Weber B L, Horsman D, Rosen B, Foulkes W D, Friedman E, Gershoni-Baruch R, Ainsworth P, Daly M, Garber J, Olsson H, Sun P, Narod S |
|
Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.
JAMA 2004 Jul 292 (4): 442-52. Green Michael J, Peterson Susan K, Baker Maria Wagner, Harper Gregory R, Friedman Lois C, Rubinstein Wendy S, Mauger David |
|
Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004 May 22 (10): 1823-9. Schwartz Marc D, Lerman Caryn, Brogan Barbara, Peshkin Beth N, Halbert Chanita Hughes, DeMarco Tiffani, Lawrence William, Main David, Finch Clinton, Magnant Colette, Pennanen Marie, Tsangaris Theodore, Willey Shawna, Isaacs Claudi |
- Page last reviewed:Jul 30, 2019
- Page last updated:Oct 31, 2019
- Content source: